NANOVIRICIDES, INC. — Director's Dealing 2014

Sep 9, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2014-09-05

Reporting Person: Diwan Anil (Director, President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-25	Common Stock, par value $0.001 per share	P	28571	$3.50	Acquired	2044918	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-25	Common Stock Warrants	$3.50	X	28571	Disposed	2014-08-15	Common Stock (28571)	Indirect

Footnotes

F1: Includes 285,714 shares issuable upon exercise of options. Does not include 1,750,000 shares of common stock underlying 500,000 shares of the Company's Series A Convertible Preferred Stock ("Series A") convertible into three and one half shares of Common Stock solely upon a change in control of the Company or upon achieving certain trading prices or 9,531,429 shares of common stock and 2,000,000 shares of Series A owned by TheraCour Pharma, Inc., over which Dr. Diwan holds voting and dispositive power.